Literature DB >> 9458459

Comparison of echocardiography with magnetic resonance imaging in the assessment of the athlete's heart.

B M Pluim1, H P Beyerbacht, J C Chin, A Zwinderman, A Van der Laarse, A De Roos, H W Vliegen, E E Van der Wall.   

Abstract

AIM: The purpose of the study was to compare the accuracy of M-mode echocardiography and two different two-dimensional echocardiographic approaches in the assessment of left ventricular mass and volumes in endurance-trained and strength-trained athletes, using magnetic resonance imaging as reference standard. METHODS AND
RESULTS: We studied 19 athletes and 10 untrained control subjects, M-mode and two-dimensional echocardiography were compared to magnetic resonance imaging. M-mode echocardiographic left ventricular mass was calculated using the Penn cube convention. Two-dimensional echocardiographic left ventricular mass was calculated using (1) the area-length method as proposed by the American Society of Echocardiography (ASE) and (2) as proposed by Reichek. The best correlation between magnetic resonance imaging and echocardiographic left ventricular mass and volumes was observed with the ASE two-dimensional echocardiographic method. The agreement between them (-3.4 +/- 7.6 g and 18.5 +/- 19.5 ml) was better than between Reichek two-dimensional echocardiography and magnetic resonance imaging (-39.4 +/- 15.4-g and 52.8 +/- 21.7 ml), and demonstrated less random difference than M-mode echocardiography and magnetic resonance imaging (3.2 +/- 21.1 g resp. 15.1 +/- 30.0 ml).
CONCLUSION: We conclude that the ASE two-dimensional echocardiographic approach, when using magnetic resonance imaging as a reference standard, was the most accurate estimator of left ventricular mass and volumes in both controls and athletes.

Mesh:

Year:  1997        PMID: 9458459     DOI: 10.1093/oxfordjournals.eurheartj.a015479

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  19 in total

Review 1.  Athlete's heart.

Authors:  Robert Fagard
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

2.  Hypertension control is needed in elderly marathon runners!

Authors:  Arnoud van der Laarse; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

3.  Left atrial and ventricular dimensions in highly trained cyclists.

Authors:  J Hoogsteen; A Hoogeveen; H Schaffers; P F F Wijn; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

4.  Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study.

Authors:  Peter J Angell; Tevfik F Ismail; Andrew Jabbour; Gillian Smith; Annette Dahl; Ricardo Wage; Greg Whyte; Daniel J Green; Sanjay Prasad; Keith George
Journal:  Eur J Appl Physiol       Date:  2014-01-28       Impact factor: 3.078

5.  Echocardiography in Takotsubo cardiomyopathy; a useful approach?

Authors:  E E van der Wall; E R Holman; A J Scholte; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-06       Impact factor: 2.357

6.  Mitral valve prolapse: a source of arrhythmias?

Authors:  E E van der Wall; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

7.  Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?

Authors:  E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

8.  Left ventricular mass assessment by CMR; how to define the optimal index.

Authors:  E E van der Wall; H M Siebelink; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-06       Impact factor: 2.357

9.  Cardiac magnetic resonance imaging in primary PCI: additional value?

Authors:  E E van der Wall; J J Bax; J W Jukema; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2009-05-26       Impact factor: 2.357

10.  Cardiovascular dynamics in ischemic cardiomyopathy during exercise.

Authors:  E E van der Wall; J J Bax; C A Swenne; P Steendijk; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.